Maroon Group Buys Lincoln Fine Ingredients

(c) Arnd Rockseri/Stockphoto
(c) Arnd Rockseri/Stockphoto

Maroon Group has acquired Lincoln Fine Ingredients, a specialty chemicals distributor based in Lincoln, Rhode Island, USA, serving the personal care, cosmetic, food & beverage, pharmaceutical and household/industrial markets.  Financial details of the transaction were not disclosed.

Mark Reichard, president and CEO of Maroon, said the deal, which has been targeted for some time, represents the group’s first foray into the personal care segment. Lincoln Fine Ingredients’ management team will remain and continue to actively manage the business.

“We’re gaining some real momentum having completed six acquisitions in less than three years, including companies operating in the CASE [coatings, adhesives, sealants and elastomers], plastics, specialty intermediates and CARE segments,” said Reichard.

Last December, Maroon acquired Cadence Chemical, a Stamford, Connecticut distributor of specialty chemicals for the CASE, chemical processing, water treatment and associated industries. Also in 2016, the Avon, Ohio-based distributor purchased U.S. Chemicals and CNX Distribution, complementing the acquisitions of D.B. Becker and Addipel in 2015 and 2014, respectively.

Maroon said it will continue to explore opportunities to form partnerships with proven entrepreneurs that have built sustainable, best-in-class distributors of specialty chemicals and ingredients.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.